Winton Group LTD Agios Pharmaceuticals, Inc. Transaction History

Winton Group LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $52,936 - $75,314	2,435 Added 11.36%	23,865 $548,000
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $471 - $598	19 Added 0.09%	21,430 $601,000
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $107,870 - $188,760	-5,529 Reduced 20.52%	21,411 $606,000
Q2 2022 Aug 10, 2022	BUY	$17.06 - $31.42 $81,922 - $150,878	4,802 Added 21.69%	26,940 $597,000
Q1 2022 May 11, 2022	BUY	$26.68 - $34.81 $90,231 - $117,727	3,382 Added 18.03%	22,138 $644,000
Q4 2021 Feb 10, 2022	SELL	$29.58 - $49.78 $347,742 - $585,213	-11,756 Reduced 38.53%	18,756 $617,000
Q3 2021 Oct 28, 2021	BUY	$41.92 - $58.18 $458,898 - $636,896	10,947 Added 55.95%	30,512 $1.41 Million
Q2 2021 Aug 10, 2021	BUY	$52.06 - $61.27 $248,065 - $291,951	4,765 Added 32.2%	19,565 $1.08 Million
Q1 2021 Jul 21, 2021	SELL	$44.23 - $57.5 $93,236 - $121,210	-2,108 Reduced 12.47%	14,800 $764,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $1.21 Million - $1.7 Million	-36,441 Reduced 68.31%	16,908 $733,000
Q3 2020 Oct 30, 2020	BUY	$33.87 - $55.93 $763,700 - $1.26 Million	22,548 Added 73.21%	53,349 $1.87 Million
Q2 2020 Aug 05, 2020	BUY	$34.45 - $53.48 $858,597 - $1.33 Million	24,923 Added 424.0%	30,801 $1.65 Million
Q1 2020 May 11, 2020	BUY	$31.52 - $53.81 $185,274 - $316,295	5,878 New	5,878 $209,000
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $324,563 - $545,866	-10,790 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$32.4 - $49.58 $349,596 - $534,968	10,790 New	10,790 $350,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.